-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| U. China News Service, September 14, According to Kyodo News Agency of Japan, two officials from the U. The reason is that existing vaccines have sufficient anti-severe effects against mutant viruses including delta strains Official The US media previously reported that the two FDA resigned because they opposed the US President Biden’s policy of vaccinating ordinary adults with the third dose of vaccine before the FDA review The article believes that under the current vaccine supply, widespread vaccination for unvaccinated populations such as developing countries can save more lives than advancing the third dose The team collected and analyzed global reports on the effectiveness of vaccines mainly from European and American manufacturers The article pointed out that for the delta strain, although the proportion of infection increased after inoculation compared to the alpha strain from the United Kingdom, the effect of preventing severe illness and hospitalization is at a higher level At present, some countries such as Israel have begun to inoculate the third dose The WHO has called on countries not to receive the third dose during the year in order to supply vaccines to developing countries The US government plans to give the third dose to people over 18 years of age who have received the second dose in the past 8 months from the 20th 17 Prior to this, FDA outside experts committee will discuss whether this is appropriate Committee members focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
Welcome to ECHEMI 
|
